These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29729320)

  • 1. CCR5Δ32 - A piece of protection in the inflammatory puzzle of multiple sclerosis susceptibility.
    Troncoso LL; Pontillo A; Oliveira EML; Finkelszteijn A; Schneider S; Chies JAB
    Hum Immunol; 2018 Aug; 79(8):621-626. PubMed ID: 29729320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the genetic variant CCR5Δ32 in HBV infection and HBV/HIV co-infection.
    Ellwanger JH; Kulmann-Leal B; Wolf JM; Michita RT; Simon D; Lunge VR; Chies JAB
    Virus Res; 2020 Feb; 277():197838. PubMed ID: 31837381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CCR5Δ32 (rs333) polymorphism has no influence on severity and mortality of influenza A(H1N1)pdm09 infection in Brazilian patients from the post pandemic period.
    Matos AR; Martins JSCC; Oliveira MLA; Garcia CC; Siqueira MM
    Infect Genet Evol; 2019 Jan; 67():55-59. PubMed ID: 30389547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5Δ32 (rs333) polymorphism is associated with the susceptibility to systemic lupus erythematosus in female Brazilian patients.
    Baltus TH; Kallaur AP; Lozovoy MA; Morimoto HK; Delongui F; Alfieri DF; Iriyoda TM; Dichi I; Simão AN; Reiche EM
    Rheumatol Int; 2016 Jan; 36(1):7-15. PubMed ID: 26071874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population.
    Kulmann-Leal B; Ellwanger JH; Chies JAB
    Front Immunol; 2021; 12():758358. PubMed ID: 34956188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association of CCR5delta32 gene mutation with multiple sclerosis in Croatian and Slovenian patients.
    Ristić S; Lovrecić L; Starcević-Cizmarević N; Brajenović-Milić B; Jazbec SS; Barac-Latas V; Vejnović D; Sepcić J; Kapović M; Peterlin B
    Mult Scler; 2006 Jun; 12(3):360-2. PubMed ID: 16764352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR5delta32 in systemic lupus erythematosus: implications for disease susceptibility and outcome in a Brazilian population.
    Schauren JS; Marasca JA; Veit TD; Monticielo OA; Xavier RM; Brenol JC; Chies JA
    Lupus; 2013 Jul; 22(8):802-9. PubMed ID: 23753295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association analysis and allelic distribution of deletion in CC chemokine receptor 5 gene (CCR5Δ32) among breast cancer patients of Pakistan.
    Fatima F; Saleem S; Hameed A; Haider G; Ali Zaidi SA; Kanwal M; Zehra S; Azhar A
    Mol Biol Rep; 2019 Apr; 46(2):2387-2394. PubMed ID: 30848448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.
    Kantarci OH; Morales Y; Ziemer PA; Hebrink DD; Mahad DJ; Atkinson EJ; Achenbach SJ; De Andrade M; Mack M; Ransohoff RM; Lassmann H; Bruck W; Weinshenker BG; Lucchinetti CF
    J Neuroimmunol; 2005 Dec; 169(1-2):137-43. PubMed ID: 16182378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CCR5 delta32 deletion with early death in multiple sclerosis.
    Gade-Andavolu R; Comings DE; MacMurray J; Rostamkhani M; Cheng LS; Tourtellotte WW; Cone LA
    Genet Med; 2004; 6(3):126-31. PubMed ID: 15354329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR5Δ32 (rs333) polymorphism is associated with decreased risk of chronic and aggressive periodontitis: A case-control analysis based in disease resistance and susceptibility phenotypes.
    Cavalla F; Biguetti CC; Dionisio TJ; Azevedo MCS; Martins W; Santos CF; Trombone APF; Silva RM; Letra A; Garlet GP
    Cytokine; 2018 Mar; 103():142-149. PubMed ID: 28969941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study.
    Rodríguez-Rodríguez L; González-Juanatey C; García-Bermúdez M; Vázquez-Rodríguez TR; Miranda-Filloy JA; Fernández-Gutiérrez B; Llorca J; Martin J; González-Gay MA
    Arthritis Res Ther; 2011 Aug; 13(4):R133. PubMed ID: 21846359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the CCR5 gene with juvenile idiopathic arthritis.
    Hinks A; Martin P; Flynn E; Eyre S; Packham J; ; Barton A; Worthington J; Thomson W
    Genes Immun; 2010 Oct; 11(7):584-9. PubMed ID: 20463745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility.
    Song GG; Lee YH
    Immunol Invest; 2014; 43(4):299-311. PubMed ID: 24295368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CCR5Δ32 polymorphism in Brazilian patients with sickle cell disease.
    Lopes MP; Santos MN; Faber EW; Bezerra MA; Hatzlhofer BL; Albuquerque DM; Zaccariotto TR; Ribeiro DM; Araújo Ada S; Costa FF; Sonati Mde F
    Dis Markers; 2014; 2014():678246. PubMed ID: 25548430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new look at osteomyelitis development--focus on CCR5delta32. Study in patients from Northeast Brazil.
    de Souza Mdo S; de Souza CA; Cunha LM; de Souza AQ; de Morais MS; Rabenhorst SH
    Infect Genet Evol; 2015 Apr; 31():61-3. PubMed ID: 25638273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
    Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
    Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C.
    Goyal A; Suneetha PV; Kumar GT; Shukla DK; Arora N; Sarin SK
    World J Gastroenterol; 2006 Aug; 12(29):4721-6. PubMed ID: 16937446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
    Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
    Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.